• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Relay Robotics Adds Three Executives to its Product Team

    FDA Clears Atalante Hands-Free Self-Balancing Device

    Kerecis Debuts New Fish-Skin Burn Products

    Accumold Compliments its Tech Capability With Micro AM

    Abbott's CardioMEMS HF System Helps Manage Heart Failure
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    CR-SOP Neurotechnology Helps to Achieve ‘Sound’ Sleep

    Inside the Hospital Value Analysis Committee

    Face Time: Why Getting Engineers Out of the Lab Is Good for Business

    Common Paratubing Pitfalls and How to Avoid Them

    During Times of Uncertainty, Create Business Value with an Optimized Workforce
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    LEMO USA Inc.

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment

    Sourcing Silicone Parts: Injection Mold or 3D Print?

    Cybersecurity in Healthcare: Getting on the Right Track
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    LEMO USA Inc.

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The TAVR Plot Thickens

    Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.

    The TAVR Plot Thickens
    Sam Brusco, Associate Editor09.06.19
    Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery. But in mid-August, TAVR’s scope was substantially expanded due to the U.S. Food & Drug Administration’s (FDA) approval of the procedure for low-risk patients using four TAVR systems: Medtronic’s CoreValve Evolut R and Evolute PRO and Edwards Lifesciences’ Sapien 3 and Sapien 3 Ultra.

    “This new approval significantly expands the number of patients that can be treated with this less invasive procedure for aortic valve replacement and follows a thorough review of data demonstrating these devices are safe and effective for this larger population,”  Bram Zuckerman, M.D., director of the Office of Cardiovascular Devices in the FDA’s Center for Devices and Radiological Health, said in a press statement. “As the FDA assesses new medical technologies or expanded uses for previously approved products such as these, the agency remains committed to evaluating evidence from clinical trials and real-world clinical data in both the premarket and postmarket settings to ensure patients have access to high-quality, safe, and effective medical devices.”

    The Evolut Low Risk Trial evaluated three valve generations—CoreValve, Evolut R, and Evolut PRO—in more than 1,400 patients. TAVR was shown to be an effective treatment option in low-risk patients, with shorter hospital stays and higher quality-of-life scores compared to surgical valve aortic replacement (SAVR). At 30 days, the Evolut TAVR achieved a significantly lower rate of the composite cause of all-cause death or disabling stroke and demonstrated superior blood flow performance compared to SAVR.

    “Low-risk patients were younger and healthier than those patients enrolled in our prior studies, and were better able to weigh the risks and benefits of surgery or TAVR based on their value preferences,” said Jeffrey J. Popma, M.D., director of Interventional Cardiology at Beth Israel Deaconess Medical Center in Boston, and co-principal investigator in the Evolut Low Risk Trial. “It is our impression that patients will now be able to make a choice on the method of aortic valve replacement based on an informed risk-benefit discussion with their heart team.”

    Edwards’ Partner 3 Trial also compared the Sapien 3 system to open-heart surgery and achieved superiority. The event rate for the trial’s primary endpoint—a composite of all-cause mortality, all stroke, and rehospitalization at one year—was a 46 percent reduction. The data was presented in March at the American College of Cardiology’s 68th Annual Scientific Session and simultaneously published in The New England Journal of Medicine.

    “The Partner 3 Trial demonstrated that low-risk patients treated with the Sapien 3 TAVR experienced extraordinary outcomes with 1 percent rates of death or disabling stroke at one year, a short length of stay and 96 percent discharged to home or self-care. Sapien 3 is the only valve to achieve superiority over surgery based on the prespecified primary endpoint,” said Martin B. Leon, M.D., director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian/Columbia University Medical Center, professor of medicine at the Columbia University College of Physicians and Surgeons, and co-principal investigator of the Partner 3 Trial.

    Though the FDA has now green-lighted TAVR for patients of all risk profiles, no cardiac procedure is without risk. A few days after granting the approvals, the FDA announced that Edwards began recalling Sapien 3 Ultra’s delivery system on July 9. Edwards initiated the recall following reports of burst balloons during implantation, which resulted in significant difficulty retrieving the valve into the catheter and withdrawing the system. When Edwards initiated the recall, 17 injuries and one death had been reported due to the burst balloons. Edwards added a warning to Sapien 3 Ultra’s Instructions for Use instructing surgeons to inflate the valve slowly and continuously throughout deployment to avoid balloon rupture.

    Perhaps in preparation for the landmark approval, the Centers for Medicare & Medicaid Services (CMS), finalized its update of the national coverage policy for TAVR in late June. The decision states TAVR is covered for treating symptomatic aortic valve stenosis “when furnished according to” an FDA-approved indication, and when all of the specific conditions are met. The valve and delivery system must have received FDA premarket approval for the system’s approved indication, which Medtronic and Edwards have now achieved for patients of any risk. The patient must also receive pre- and post-op care from a heart team that is “a cohesive, multi-disciplinary team of healthcare professionals,” including a cardiac surgeon and interventional cardiologist experienced in aortic stenosis treatment. They must have each examined the patient face-to-face and evaluated suitability for SAVR, TAVR, or palliative therapy and demonstrated the rationale for their judgment.

    Hospitals providing TAVR must have “appropriate infrastructure that includes but is not limited to” onsite valve surgery and interventional cardiology programs and a post-procedure intensive care facility with personnel experienced in valve procedures. Hospitals beginning a TAVR program without previous experience must have, at least: 50 open heart surgeries in the year prior to program initiation, 20 aortic-valve-related procedures two years prior, two physicians with cardiac surgery privileges, at least one physician with interventional cardiology privileges, and 300 percutaneous coronary interventions per year.

    Adding to the fray, Boston Scientific’s Lotus Edge TAVR gained FDA approval in April and Edwards discontinued work on its Centera valve in July to focus on Sapien 3. The treatment narrative is shifting, and TAVR is beginning to take the lead. 
    Related Searches
    • tavr
    • program
    • quality
    • boston scientific
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    CareDx Appoints Hannah Valantine to its Board CareDx Appoints Hannah Valantine to its Board
    The Benefits of Computer Vision Technology for Healthcare Applications The Benefits of Computer Vision Technology for Healthcare Applications
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Abbott Buys Walk Vascular, a Thrombectomy System Maker Abbott Buys Walk Vascular, a Thrombectomy System Maker
    Sectoral Asset Management Invests $9M in Cagent Vascular Sectoral Asset Management Invests $9M in Cagent Vascular
    Ramin Mousavi Appointed CEO of CathWorks Ramin Mousavi Appointed CEO of CathWorks
    CVRx Completes First Procedure With Ultrasound-Guided Implant Approach CVRx Completes First Procedure With Ultrasound-Guided Implant Approach
    Biomedical Engineers Grow 3D Bioprinted Blood Vessel Biomedical Engineers Grow 3D Bioprinted Blood Vessel
    Developing Next Generation Implants with Bioresorbables—A Medtech Makers Q&A Developing Next Generation Implants with Bioresorbables—A Medtech Makers Q&A
    HD Medical Appoints Shaun Setty as Chief Medical Officer HD Medical Appoints Shaun Setty as Chief Medical Officer
    First Clinical Use of SoundBite Medical First Clinical Use of SoundBite Medical's Active Wire Platform
    Early Catheter Ablation of VT Outperforms Conventional Medical Therapy Early Catheter Ablation of VT Outperforms Conventional Medical Therapy
    FDA OKs Abbott FDA OKs Abbott's AI OCT Imaging for Vessels in the Heart
    Hello Heart Raises $45M to Expand Digital Heart Health Platform Hello Heart Raises $45M to Expand Digital Heart Health Platform
    Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy Promaxo Taps Srirama Venkataraman as VP of Clinical Research & Strategy

    Related Breaking News

    • CareDx Appoints Hannah Valantine to its Board

      CareDx Appoints Hannah Valantine to its Board

      Valantine is a professor of Medicine at Stanford and the former National Institutes of Health chief scientific officer for Scientific Workforce Diversity.
      Globe Newswire 09.21.21

    • Digital Health
      The Benefits of Computer Vision Technology for Healthcare Applications

      The Benefits of Computer Vision Technology for Healthcare Applications

      How new technology could save millions of dollars and help patients receive better treatment.
      Henry Bell, Head of Product at Vendorland 09.13.21

    • RapidPulse Closes $15 Million Series A Financing

      RapidPulse Closes $15 Million Series A Financing

      Two industry veterans join the team to support the development of a cyclic aspiration system for ischemic stroke.
      Globe Newswire 09.10.21


    • Cardiovascular
      Abbott Buys Walk Vascular, a Thrombectomy System Maker

      Abbott Buys Walk Vascular, a Thrombectomy System Maker

      Adds mechanical thrombectomy devices for treating patients with peripheral blood clots.
      PR Newswire 09.02.21

    • Sectoral Asset Management Invests $9M in Cagent Vascular

      Sectoral Asset Management Invests $9M in Cagent Vascular

      Money will be used to help manufacture and commercialize the Serranator product.
      Business Wire 09.01.21

    Loading, Please Wait..

    Trending
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • The Future Of Biomedical Engineering Advancements
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    • 7 Steps To Create Your Own Medical Device Marketing Plan
    Breaking News
    • Relay Robotics Adds Three Executives to its Product Team
    • FDA Clears Atalante Hands-Free Self-Balancing Device
    • Kerecis Debuts New Fish-Skin Burn Products
    • Accumold Compliments its Tech Capability With Micro AM
    • Abbott's CardioMEMS HF System Helps Manage Heart Failure
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOOD Meat Receives FDA Go-Ahead for Cultured Meat
    IFF Achieves Industrial-Scale Production of Anaerobic Probiotic Strain
    Jones Healthcare Group Primed to Help Nutraceutical Brands Comply with New Packaging Rules
    Coatings World

    Latest Breaking News From Coatings World

    Orion Debottlenecks Plant in Germany for High-Jetness Carbon Blacks
    Barentz Expands Market Acceleration Team
    Röhm Launches DEGALAN proTerra
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Relay Robotics Adds Three Executives to its Product Team
    FDA Clears Atalante Hands-Free Self-Balancing Device
    Kerecis Debuts New Fish-Skin Burn Products
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Hovione, Laxxon Medical Partner on 3D Screen Printed Pharmaceutical Apps
    Stäubli Robotics to Showcase Next Gen Pharma Robots at Interphex 2023
    Remedium, Exothera Partner on Scale-Up, Demonstration Runs for AAV2-FGF18
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Wella Company Appoints Frank Smalla as Chief Financial Officer & Chief Operating Officer
    True Botanicals Secures Series B Investment from NextWorld Evergreen
    LVMH Appoints Giulio Bergamaschi as CEO of Acqua di Parma
    Happi

    Latest Breaking News From Happi

    True Botanicals Announces Series B Investment From NextWorld Evergreen
    Rodan + Fields Celebrates 15 Years with Limited-Edition Birthday Box
    Johnson’s Baby Releases Body Wash, Shampoo and Face and Body Cream for Sensitive Skin
    Ink World

    Latest Breaking News From Ink World

    Markem-Imaje Introduces New Hybrid Continuous Inkjet Printer
    Orion Debottlenecks German Facility for High-Jetness Carbon Blacks
    Barentz Expanding Market Acceleration Team
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Mark Andy introduces ProWORX Label Suite
    Brook + Whittle to install first HP Indigo V12 digital press in US
    HP debuts HP Indigo 200K digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Berry Releases 2022 Impact Report
    Kimberly-Clark Ranks Third Among 100 Most Sustainable Companies
    Weekly Recap: TerraCycle Launches Diaper Program, Ahlstrom to Divest or Shutter Stenay Plant & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Head and Neck Injury Severity Rising in High School Athletes
    Loci Orthopaedics Earns New Patent for Thumb Base Joint Implant System
    Study: Running Does Not Increase Arthritis Risk
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    NextFlex Launches $4.4 Million Funding Opportunity
    Confidex Partners with Mesh Specialist Wirepas
    Waterman Onions Digitizes Logistics Operation with Zebra

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login